| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 496,825 | 517,508 | 425,800 | 407,814 | | Cost of Revenue | 225,944 | 380,286 | 315,659 | 311,032 | | | Gross Profit | 270,881 | 137,222 | 110,141 | 96,782 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 172,612 | 23,675 | 21,788 | 22,980 | | Non Recurring | 1,688 | 5,116 | 1,311 | 110,664 | | Others | 38,508 | 37,881 | 36,456 | 42,567 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 55,671 | 70,550 | 50,586 | (79,429) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,096 | (20,359) | 8,477 | 13,893 | | Earnings Before Interest And Taxes | 60,134 | 49,776 | 58,458 | (68,029) | | Interest Expense | 25,893 | 25,649 | 25,464 | 26,311 | | Income Before Tax | 34,241 | 24,127 | 32,994 | (94,340) | | Income Tax Expense | 12,186 | 4,320 | 14,643 | (4,793) | | Minority Interest | (2,967) |
-
|
-
| (120) | | | | Net Income From Continuing Ops | (9,845) | 19,807 | 18,351 | (89,547) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,088 | 19,807 | 18,351 | (89,547) | | Preferred Stock And Other Adjustments | 1,923 | (1,137) | (786) |
-
| | | Net Income Applicable To Common Shares | $21,011 | $18,670 | $17,565 | ($89,547) |
|
0.83% Nasdaq 
Income Statement
